| 产品描述: | Velufenacin is an antagonist of muscarinic receptor |
| 靶点: |
AChR |
| 体内研究: |
Intravenous administration of Velufenacin dose dependently inhibited rhythmic urinary bladder contractions induced by distension in rats with ID30= 0.08 mg/kg |
| 参考文献: |
1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 33, No. 4, 2019. 2. Lee MJ, et al. Pharmacological characterization of DA-8010, a novel muscarinic receptor antagonist selective for urinary bladder over salivary gland. Eur J Pharmacol. 2019 Jan 15;843:240-250. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.756 ml |
13.781 ml |
27.561 ml |
| 5 mM |
0.551 ml |
2.756 ml |
5.512 ml |
| 10 mM |
0.276 ml |
1.378 ml |
2.756 ml |
| 50 mM |
0.055 ml |
0.276 ml |
0.551 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |